UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Adrenal Steroid Metabolites Accumulating in Congenital Adrenal Hyperplasia Lead to Transactivation of the Glucocorticoid Receptor

Endocrinology (Philadelphia), 2015-10, Vol.156 (10), p.3504-3510

2015

Volltextzugriff (PDF)

Comparing cisplatin-based combination chemotherapy with EMA/CO chemotherapy for the treatment of high risk gestational trophoblastic neoplasia

European journal of cancer (1990), 2013-03, Vol.49 (4), p.860-867

2013

Volltextzugriff (PDF)

Tamoxifen sensitivity and estrogen receptor mRNA levels

Breast cancer research and treatment, 2010-06, Vol.121 (3), p.793-794

2010

Volltextzugriff (PDF)

Human chorionic gonadotropin (hCG) regression normograms for patients with high-risk gestational trophoblastic neoplasia treated with EMA/CO (etoposide, methotrexate, actinomycin D, cyclophosphamide and vincristine) chemotherapy

Annals of oncology, 2012-11, Vol.23 (11), p.2903-2906

2012

Volltextzugriff (PDF)

Trends in incidence for gestational trophoblastic disease over the last 20 years in a population-based study

Gynecologic oncology, 2016-01, Vol.140 (1), p.70-75

2016

Volltextzugriff (PDF)

The added value of hysterectomy in the management of gestational trophoblastic neoplasia

Gynecologic oncology, 2017-06, Vol.145 (3), p.536-542

2017

Volltextzugriff (PDF)

Can the FIGO 2000 scoring system for gestational trophoblastic neoplasia be simplified? A new retrospective analysis from a nationwide dataset

Annals of oncology, 2017-08, Vol.28 (8), p.1856-1861

2017

Volltextzugriff (PDF)

Relapse rates after two versus three consolidation courses of methotrexate in the treatment of low-risk gestational trophoblastic neoplasia

Gynecologic oncology, 2012-06, Vol.125 (3), p.576-579

2012

Volltextzugriff (PDF)

Randomized Adjuvant Chemotherapy Trial in High-Risk, Lymph Node-Negative Breast Cancer Patients Identified by Urokinase-Type Plasminogen Activator and Plasminogen Activator Inhibitor Type 1

JNCI : Journal of the National Cancer Institute, 2001-06, Vol.93 (12), p.913-920

2001

Volltextzugriff (PDF)

Improved metastasis‐free survival in nonadjuvantly treated postmenopausal breast cancer patients with chemokine receptor 5 del32 frameshift mutations

International journal of cancer, 2015-01, Vol.136 (1), p.91-97

2015

Volltextzugriff (PDF)

Fatal cases of gestational trophoblastic neoplasia over four decades in the Netherlands: a retrospective cohort study

BJOG : an international journal of obstetrics and gynaecology, 2012-11, Vol.119 (12), p.1465-1472

2012

Volltextzugriff (PDF)

Angiogenesis, hypoxia and VEGF expression during tumour growth in a human xenograft tumour model

Microvascular research, 2009-03, Vol.77 (2), p.96-103

2009

Volltextzugriff (PDF)

Harmonisation of multi-centre real-time reverse-transcribed PCR results of a candidate prognostic marker in breast cancer: An EU-FP6 supported study of members of the EORTC – PathoBiology Group

European journal of cancer (1990), 2009-01, Vol.45 (1), p.74-81

2009

Volltextzugriff (PDF)

Carbonic anhydrase IX expression is more predictive than prognostic in breast cancer

British journal of cancer, 2007-04, Vol.96 (8), p.1309-1309

2007

Volltextzugriff (PDF)

Plasminogen activators are involved in angiostatin generation in vivo in benign and malignant ovarian tumor cyst fluids

International journal of oncology, 2014-04, Vol.44 (4), p.1394-1400

2014

Volltextzugriff (PDF)

Independent and functional validation of a multi-tumour-type proliferation signature

British journal of cancer, 2012-07, Vol.107 (3), p.508-515

2012

Volltextzugriff (PDF)

DC-SCRIPT: Nuclear Receptor Modulation and Prognostic Significance in Primary Breast Cancer

JNCI : Journal of the National Cancer Institute, 2010-01, Vol.102 (1), p.54-68

2010

Volltextzugriff (PDF)

Risk factors for second‐line dactinomycin failure after methotrexate treatment for low‐risk gestational trophoblastic neoplasia: a retrospective study

BJOG : an international journal of obstetrics and gynaecology, 2020-08, Vol.127 (9), p.1139-1145

2020

Volltextzugriff (PDF)

Early identification of treatment resistance in GTN

The lancet oncology, 2007-10, Vol.8 (10), p.866-867

2007

Volltextzugriff (PDF)

Pooled Analysis of Prognostic Impact of Urokinase-Type Plasminogen Activator and Its Inhibitor PAI-1 in 8377 Breast Cancer Patients

JNCI : Journal of the National Cancer Institute, 2002-01, Vol.94 (2), p.116-128

2002

Volltextzugriff (PDF)

Development of ELISAs for quantification of HMFG1-specific human anti-mouse IgG and IgM antibodies

The International journal of biological markers, 2007-07, Vol.22 (3), p.167-171

2007

Volltextzugriff (PDF)

Clinical utility of hyperglycosylated hCG in serum taken before hydatidiform mole evacuation to predict persistent trophoblastic disease

The International journal of biological markers, 2006, Vol.21 (1), p.45-49

2006

Volltextzugriff (PDF)

Interleukin-1-induced nonspecific resistance to bacterial infection in mice is not mediated by glucocorticosteroids

Antimicrobial Agents and Chemotherapy, 1992-12, Vol.36 (12), p.2785-2789

1992

Volltextzugriff (PDF)

Ten-year analysis of the prospective multicentre Chemo-N0 trial validates American Society of Clinical Oncology (ASCO)-recommended biomarkers uPA and PAI-1 for therapy decision making in node-negative breast cancer patients

European journal of cancer (1990), 2013-05, Vol.49 (8), p.1825-1835

2013

Volltextzugriff (PDF)

Immunochemical and Mass-Spectrometry-Based Serum Hepcidin Assays for Iron Metabolism Disorders

Clinical chemistry (Baltimore, Md.), 2010-10, Vol.56 (10), p.1570-1579

2010

Volltextzugriff (PDF)

1 – 25 von 71

Suche als RSS-Feed

Aktive Filter

ThemaMale

KollektionMEDLINE

ThemaScience & Technology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(69)
Mit Volltextzugriff
(63)

Publikationsform

Artikel
(71)

Sprache

Englisch
(71)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(69)
Humans
(66)
Female
(57)
Oncology
(47)
Biological And Medical Sciences
(38)
Medical Sciences
(35)
Adult
(29)
Middle Aged
(23)
Pregnancy
(23)
Tumors
(23)
Obstetrics & Gynecology
(20)
Gynecology. Andrology. Obstetrics
(18)
Prognosis
(15)
Chorionic Gonadotropin - Blood
(13)
Aged
(12)
Animals
(12)
Hematology, Oncology And Palliative Medicine
(12)
Mice
(11)
Pharmacology. Drug Treatments
(11)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Adrenal Steroid Metabolites Accumulating in Congenital Adrenal Hyperplasia Lead to Transactivation of the Glucocorticoid Receptor

Comparing cisplatin-based combination chemotherapy with EMA/CO chemotherapy for the treatment of high risk gestational trophoblastic neoplasia

Tamoxifen sensitivity and estrogen receptor mRNA levels

Human chorionic gonadotropin (hCG) regression normograms for patients with high-risk gestational trophoblastic neoplasia treated with EMA/CO (etoposide, methotrexate, actinomycin D, cyclophosphamide and vincristine) chemotherapy

Trends in incidence for gestational trophoblastic disease over the last 20 years in a population-based study

The added value of hysterectomy in the management of gestational trophoblastic neoplasia

Can the FIGO 2000 scoring system for gestational trophoblastic neoplasia be simplified? A new retrospective analysis from a nationwide dataset

Relapse rates after two versus three consolidation courses of methotrexate in the treatment of low-risk gestational trophoblastic neoplasia

Randomized Adjuvant Chemotherapy Trial in High-Risk, Lymph Node-Negative Breast Cancer Patients Identified by Urokinase-Type Plasminogen Activator and Plasminogen Activator Inhibitor Type 1

Improved metastasis‐free survival in nonadjuvantly treated postmenopausal breast cancer patients with chemokine receptor 5 del32 frameshift mutations

Fatal cases of gestational trophoblastic neoplasia over four decades in the Netherlands: a retrospective cohort study

Angiogenesis, hypoxia and VEGF expression during tumour growth in a human xenograft tumour model

Harmonisation of multi-centre real-time reverse-transcribed PCR results of a candidate prognostic marker in breast cancer: An EU-FP6 supported study of members of the EORTC – PathoBiology Group

Carbonic anhydrase IX expression is more predictive than prognostic in breast cancer

Plasminogen activators are involved in angiostatin generation in vivo in benign and malignant ovarian tumor cyst fluids

Independent and functional validation of a multi-tumour-type proliferation signature

DC-SCRIPT: Nuclear Receptor Modulation and Prognostic Significance in Primary Breast Cancer

Risk factors for second‐line dactinomycin failure after methotrexate treatment for low‐risk gestational trophoblastic neoplasia: a retrospective study

Early identification of treatment resistance in GTN

Pooled Analysis of Prognostic Impact of Urokinase-Type Plasminogen Activator and Its Inhibitor PAI-1 in 8377 Breast Cancer Patients

Development of ELISAs for quantification of HMFG1-specific human anti-mouse IgG and IgM antibodies

Clinical utility of hyperglycosylated hCG in serum taken before hydatidiform mole evacuation to predict persistent trophoblastic disease

Interleukin-1-induced nonspecific resistance to bacterial infection in mice is not mediated by glucocorticosteroids

Ten-year analysis of the prospective multicentre Chemo-N0 trial validates American Society of Clinical Oncology (ASCO)-recommended biomarkers uPA and PAI-1 for therapy decision making in node-negative breast cancer patients

Immunochemical and Mass-Spectrometry-Based Serum Hepcidin Assays for Iron Metabolism Disorders

Aktive Filter

Suchergebnisse filtern